Table 2.
Prevalence of Cholesterol-Lowering Medication Use from 1997–2008
| 1997–1998 (n=3055) | 1998–1999 (n=2908) | 1999–2000 (n=2820) | 2001–2002 (n=2631) | 2002–2003 (n=2515) | 2004–2005 (n=1780) | 2006–2007 (n=1592) | 2007–2008 (n=1344) | |
|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | |
| Any cholesterol lowering medications | 456 (14.9) | 509 (17.5) | 586 (20.8) | 702 (26.7) | 737 (29.3) | 656 (36.9) | 676 (42.5) | 573 (42.6) |
|
| ||||||||
| Any statins | 395 (12.9) | 461 (15.9) | 542 (19.2) | 654 (24.9) | 695 (27.6) | 615 (34.6) | 620 (38.9) | 525 (39.1) |
| Any fibrates | 35 (1.2) | 30 (1.0) | 32 (1.1) | 33 (1.3) | 29 (1.2) | 29 (1.6) | 33 (2.0) | 28 (2.1) |
| Any bile acid sequestrants, probucol, niacins | 43 (1.4) | 33 (1.1) | 33 (1.2) | 35 (1.3) | 40 (1.6) | 21 (1.2) | 21 (1.3) | 21 (1.6) |
| Any ezetimibe | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (0.1) | 38 (2.1) | 77 (4.8) | 69 (5.1) |